A combination of various technologies in pharmacometabolomics enables biomarker discovery for prediction of drug responses of individual patients.
Pharmacometabolomics provides biomarkers for precision medicine
read more
All posts to the category
A combination of various technologies in pharmacometabolomics enables biomarker discovery for prediction of drug responses of individual patients.
Cancer in comparison to chemotherapy cause distinct metabolic perturbations, which both lead to the development and progression of cachexia characterized by extreme weight loss and muscle wasting.
The metabolome differentiates athlete phenotypes
Population-based cohort study reveals link between proton pump inhibitor intake and increasing risk for cardiovascular events.
A metabolic pattern of patients with irritable bowel syndrome (IBS) was identified, providing the key to non-invasive IBS diagnostics.